Safety Services: Critical Component of Clinical Trials
Discover the critical role of Safety Services in clinical trials and how to select the right pharmacovigilance (PV) vendor. It highlights the key evaluation criteria—such as experience, regulatory knowledge, flexibility, communication, technology expertise, and cost. It also details the importance of asking deeper, more strategic questions, particularly around QC team expertise and undetected errors. The whitepaper underscores the value of proactive, adaptable, and tech-savvy PV partners in ensuring high-quality data, regulatory compliance, and trial success across the full product lifecycle.
Related Resources
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...